Dynavax Technologies Corp logo

Dynavax Technologies Corp

$ 12.23 -0.245 (-1.96%) 03:35 PM EST
P/E:
8.61
P/B:
3.63
Market Cap:
$ 1.52B
Enterprise V:
$ 1.33B
Volume:
1.74M
Avg Vol (2M):
2.06M
Also Trade In:
Volume:
1.74M
Market Cap $:
1.52B
PE Ratio:
8.61
Avg Vol (2-Month):
2.06M
Enterprise Value $:
1.33B
PB Ratio:
3.63
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Dynavax Technologies Corp
NAICS : 325412 SIC : 2834
2100 Powell Street, Suite 900, Emeryville, CA, USA, 94608
Description
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product.
Name Current Vs Industry Vs History
Cash-To-Debt 2.01
Equity-to-Asset 0.41
Debt-to-Equity 0.61
Debt-to-EBITDA 1.04
Interest Coverage 37.78
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.28
Distress
Grey
Safe
Beneish M-Score 0.13
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 193.3
3-Year Book Growth Rate 21.7
Name Current Vs Industry Vs History
5-Day RSI 15.08
9-Day RSI 27.47
14-Day RSI 35.67
6-1 Month Momentum % 12.8
12-1 Month Momentum % 17.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.77
Quick Ratio 2.55
Cash Ratio 1.5
Days Inventory 104.38
Days Sales Outstanding 78.95
Days Payable 12.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.1

Financials (Next Earnings Date:2022-11-04 Est.)

DVAX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:DVAX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 673.796
EPS (TTM) ($) 1.4
Beta 1.44
Volatility % 121.79
14-Day RSI 35.67
14-Day ATR ($) 0.936454
20-Day SMA ($) 15.032
12-1 Month Momentum % 17.87
52-Week Range ($) 7.26 - 21.39
Shares Outstanding (Mil) 126.47

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Dynavax Technologies Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More